R
Royalty Pharma plc (RPRX)
NMS – Real Time Price. Currency in USD
46.35
-0.59 (-1.26%)
At close: Mar 27, 2026, 4:00 PM EDT
46.35
0.00 (0.00%)
After-hours: Mar 27, 2026, 6:10 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
46.35
-0.59 (-1.26%)
At close: Mar 27, 2026, 4:00 PM EDT
46.35
0.00 (0.00%)
After-hours: Mar 27, 2026, 6:10 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.40 | 6.05 | 10 | |
| Quick ratio | 2.40 | 5.63 | 10 | |
| Debt to Equity | 1.38 | 0.30 | 5.0 | |
| Debt to Assets | 0.46 | 1.04 | 5.0 | |
| Interest coverage | 4.12 | -16.91 | 10 | |
| Weighted average score | 8.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 2.24B | 2.35B | 2.26B | 2.38B | 2.38B |
| Gross Profit | 2.23B | N/A | N/A | 2.37B | 1.23B |
| Operating Income | 923M | 1.49B | 1.29B | 1.56B | 1.56B |
| Net Income | 43M | 1.13B | 859M | 771M | 771M |
| EBITDA | 929M | 1.49B | 1.29B | 1.56B | 1.56B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -1.45 | 43.42 | 5.5 |
| Next quarter | -3.22 | 5.03 | 3.0 |
| Current year | 0.01 | 0.53 | 2.0 |
| Next year | 7.04 | 8.19 | 5.5 |
| Weighted average score | 4.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 2.09 | -25.74 | 24.94 | 18.28 | 5.8 |
| Y/Y | 4.71 | 2.88 | 27.34 | 11.58 | 6.3 |
| 3y average | 2.15 | 838.32 | 10.27 | 8.82 | 6.5 |
| 5y average | 2.41 | 477.09 | 15.29 | 6.23 | 6.8 |
| Weighted average score | 6.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 2.42 | 2.42 | 7.0 |
| Payout ratio | 17.18 | 17.18 | 3.0 |
| 5-year dividend growth rate | 24.01 | 24.01 | 10 |
| Years of dividend increase | 5.00 | 5.00 | 5.0 |
| Weighted average score | 6.3 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Wide | 8.0 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Medium | 7.0 |
| Network effect | Medium | 6.0 |
| Economies of scale | Wide | 8.0 |
| Weighted average score | 7.4 | |
Total debt $9.0B significantly exceeds cash reserves ($618.7M), raising financial stability concerns
Total current assets $1.5B exceed Total current liabilities $636.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.9) is near the industry average, reflecting balanced leverage
Interest coverage ratio (4x) indicates the company easily manages its debt payments
The company generates positive free cash flow $832.1M, supporting its financial health